Health

Scholars discuss the need for federal regulations to combat risks associated with technology in health care.

The Supreme Court must maintain pregnant people’s right to receive emergency medical care—including abortion.

Australia implements a new framework for regulating the medicinal use of psychedelic substances such as MDMA and psilocybin.

The government should lower regulatory hurdles impeding psilocybin assisted psychotherapy research.

Dispensaries could fill the regulatory void for psychedelics and promote public health.

Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.

Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.

Experts discuss the benefits and drawbacks of existing regulatory frameworks for psychedelics.

The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.

Allison K. Hoffman discusses the role of state ballot initiatives, federal law, and private equity in the U.S. health care system.

OSHA should use machine learning to improve the effectiveness of its regulatory inspections.

Scholar calls for regulation to counter cigarette addiction while limiting increased vaping among non-smokers.